Zai Lab Partner MacroGenics Announces FDA Approval of MARGENZA™ for Patients with Pretreated Metastatic HER2-Positive Breast Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. ACN
2. ONON
3. IAUX
4. KKR
5. LLY
6. DAVA
7. MONC:IM
8. MONRY
9. NYXH
10. PNR

Go back to Zai Lab Partner MacroGenics Announces FDA Approval of MARGENZA™ for Patients with Pretreated Metastatic HER2-Positive Breast Cancer
MACROGENICS (NASDAQ: MGNX) Delayed: 4.12 --0 (-0%)
Previous Close $4.12    52 Week High $36.11 
Open $4.12    52 Week Low $14.84 
Day High $4.12    P/E 10.56 
Day Low $4.12    EPS $0.39 
Volume 250